Respiratory syncytial virus vaccine under trial aims at eliminating childhood illness
ABCWhen Alyssa Kremer's three-year-old son Harrison got sick earlier this year, she thought it was just his asthma. Key points: Respiratory syncytial virus is a common and highly infectious virus that most children will catch before they turn two Queensland researchers are working on a vaccine that would be given to pregnant women The vaccine would stimulate a women's immune response and pass on antibodies to the baby "He actually fell asleep on the couch, which was quite abnormal for him to do in the middle of the day, and I tried to wake him up, and he suddenly stopped breathing." Vaccine development Researchers from the Mater Mothers' Hospital in Brisbane hope a vaccine being developed and tested at the moment could "relegate RSV to the history books". Glenn Gardiner, director of the hospital's maternal fetal medicine service, is leading the trial and said the vaccine was entering a major phase of testing, after five years of research. Dr Gardiner said the vaccine worked by stimulating a pregnant women's immune response to the virus.
History of this topic
RSV vaccine: Who is eligible and what does it do?
The Independent
FDA approves vaccine-like RSV shot for infants
SalonRespiratory syncytial virus cases close to 10 times higher in some states, as testing rates increase
ABC
Europe OKs first one-dose drug to protect babies against RSV
LA Times
Pfizer's new RSV vaccine given to pregnant women to protect their babies shows major promise
Daily Mail
New RSV treatment could be a game changer, Dutch researcher says
NL TimesDiscover Related
